Subscribe To
Stock split watch: 1 magnificent growth stock up 928% in 10 years to buy now and hold forever
Forward stock splits follow substantial share price appreciation, which itself often points to financial fortitude. MercadoLibre's share price increas...
September 26, 2023, 5:54 am
Oneup trader review 2023 – expert trader insights
OneUp Trader Review Proprietary trading firms provide financial backing to traders, allowing them to trade with the firm’s capital. OneUp Trader is ...
September 26, 2023, 1:26 am
If you invested $100 in bitcoin, ethereum, and dogecoin when joe biden took office, here’s how much you’d have now
A look at how three major cryptocurrencies have performed since Joe Biden took office. Several 2024 presidential ...
September 25, 2023, 3:29 pm
Uaw's shawn fain done 'masterful' job in big 3 strike: autoblog editor
Auto workers carry over their strike against the Big Three automakers Ford (F), General Motors (GM), Stellantis (STLA) into its second week. Autoblog ...
September 25, 2023, 3:28 pm
Revolution medicines: a big pipeline in need of big data
Revolution Medicines, Inc. has a diversified pipeline of drugs but is still searching for its flagship project, making it a high-risk investment. The ...
September 25, 2023, 3:24 pm
An updated view on fulcrum therapeutics
Fulcrum Therapeutics, Inc. has had some key potential catalysts resolved positively recently. These included the FDA lifted the clinical hold on Fulcr...
September 25, 2023, 2:10 pm
4d molecular therapeutics: some failures, a few key successes
4D Molecular Therapeutics, Inc. has faced setbacks, with the FDA placing a clinical hold on its Fabry Disease program due to serious kidney conditions...
September 25, 2023, 12:19 pm
Transcode therapeutics stock skyrockets on positive brain cancer trial results
TransCode Therapeutics (NASDAQ:RNAZ) shares took off after it announced positive results from a study of its lead drug ...
September 25, 2023, 10:38 am
Biophytis shares surge 41% following covid partnership with france's skyepharma
Shares of Biophytis (NASDAQ:BPTS, EPA:ALBPS), a clinical-stage biotechnology firm, soared 41% in premarket trading on Nasdaq following the announcemen...
September 25, 2023, 9:12 am
Cybin to participate in the cantor global healthcare conference
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company co...
September 25, 2023, 7:30 am
Is datadog a buyout target after cisco's splunk acquisition?
As a monitoring platform for cloud-based apps, Datadog Inc NASDAQ: DDOG has tremendous long-term growth potential tied to enterprise digital transform...
September 25, 2023, 7:00 am
Kura's ziftomenib: the swiss army knife in aml therapy
Kura Oncology's lead candidate, ziftomenib, shows dual-functionality in treating NPM1-mutant AML and ov...
September 25, 2023, 4:40 am
Oxford cannabinoid technologies completes final dose in phase i trial of lead asset
Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) has successfully administered the final dose of its lead drug ...
September 25, 2023, 2:47 am
Week in review: everest acquires novel autoimmune therapy in $132 million agreement
Shanghai Everest Medicines acquired China/Asian rights to a novel therapy for autoimmune diseases from Kezar Life Sciences of South San Francisco in a...
September 24, 2023, 10:33 pm
Study abroad scholarships: applications open for new zealand excellence awards
Interested candidates have time till October 15 to apply for these scholarships at the official website...
September 24, 2023, 11:44 am
: ‘i’ll raise the retirement age – only for younger people’ to save social security, republican presidential candidate nikki haley says
Republican candidate Nikki Haley wants to raise retirement age, limit benefits for some, to save Social...
September 23, 2023, 5:41 pm
Better gene editing stock: intellia therapeutics vs. rocket pharmaceuticals
Rocket Pharmaceuticals has two programs approaching commercialization. By contrast, Intellia's candidat...
September 23, 2023, 9:45 am
Abbvie terminates deal with i-mab to develop cancer drug
China-based biotech company I-Mab said on Friday that AbbVie has terminated a 2020 deal to co-develop and market I-Mab's lead cancer drug ...
September 22, 2023, 5:09 pm
Immix (immx) up on orphan drug tag for al amyloidosis therapy
Immix (IMMX) gets ODD designation in the United States for lead candidate NXC-201 for the treatment of ...
September 22, 2023, 1:31 pm
Farfetch: negative sentiment but this company has strengths
Farfetch is well positioned in the luxury market and protected by barriers to entry. However, their financial situation and missed guidance have cause...
September 22, 2023, 9:31 am